Skip to main content

Table 1 Characteristics of the included studies in this systematic Review and meta analyses

From: Uncovering the extent of dementia prevalence in Iran: a comprehensive systematic review and meta-analysis

Author

Published year

City

Age range

Studied Population

Diagnostic Criteria

No of Alzheimer /dementia patience

NOS *

Selection

Comparability

Outcome

Sadegi M

2004

Tehran

65 years ≤

279 Convenience Sampling, 26 center nursing home

DSM-IV

121

**

*

***

Mohammadi A [12]

2012

Boyerahmad

65 years ≤

804 Stratified three

stage cluster sampling

Persian version of

Clinical Dementia Rating Scale (CDR)

Moderate and Sever Dementia were included)

85

***

*

***

Sharifi F

2016

Alborz

60-80years ≤

227 Multi-stratified cluster proportionate random sampling method

Brief Cognitive Assessment Tool (BCAT) In briefly: the impairment in the three-word recall test as well as the inability in one of the mentioned domains of ADLs.

15

*****

**

***

Sharifi F

2016

E. zerbaijan

60-80years ≤

403 Multi-stratified cluster proportionate random sampling method

//

20

*****

**

***

Sharifi F

2016

Khuzestan

60-80years ≤

353 Multi-stratified cluster proportionate random sampling method

//

34

*****

**

***

Sharifi F

2016

N.Khorasan

60-80years ≤

96 Multi-stratified cluster proportionate random sampling method

//

14

*****

**

***

Sharifi F

2016

S. & Balouchestan

60-80years ≤

178 Multi-stratified cluster proportionate random sampling method

//

19

*****

**

***

Gholamzadeh S

2017

Shiraz

60 years ≤

2000 Random sample health center

Mini-mental state exam(MMSE)/geriatric depression scales (GDS)

46

*****

**

***

Kamalzadeh L

2019

Tehran

60 years ≤

205 Hospital based sampling

DSM-5

45

***

**

***

Davarinejad O

2019

Kermanshah

< 25–50≤

275 Hospital base random sampling

-

5

***

**

***

GBD DC ^

2019

World / part of it is about Iran

60 years ≤

4,361,843 Tehran&Babol Universities of Medical Sciences

DSM; DSM-III, DSM-IV, or DSM-5)

368,528

***

**

***

Hosseinzadeh A

2022

Iran

60 years ≤

Indirect Estimation of Dementia Prevalence and Its Geographical Variation Using the Claim Data in Iran

The frequency of prescribed specialized medicines in one year by generic and brand names in each province

508.9 per 100,000

***

**

***

BBC Report 2019 [13]

2018

Iran

60 years ≤

General Population

-

700,000

-

-

-

  1. * Newcastle-Ottawa Scale (NOS) Illustrating the Criteria for Allocating Stars to Assess the Quality of Studies
  2. ^ GBD 2016 Dementia Collaborators